Dr Luke Gildo Mirabelli, MD | |
3901 Rainbow Blvd # Ms 1060, Kansas City, KS 66160-8500 | |
(913) 588-5276 | |
(913) 588-3974 |
Full Name | Dr Luke Gildo Mirabelli |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 3901 Rainbow Blvd # Ms 1060, Kansas City, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710447255 | NPI | - | NPPES |
94-09805 | Other | KS | KANSAS STATE BOARD OF HEALING ARTS |
2023025341 | Other | MO | MISSOURI STATE BOARD OF REGISTRATION FOR THE HEALING ARTS |
Mailing Address | Practice Location Address |
---|---|
Dr Luke Gildo Mirabelli, MD 3901 Rainbow Blvd # Ms 1060, Kansas City, KS 66160-8500 Ph: (913) 588-5000 | Dr Luke Gildo Mirabelli, MD 3901 Rainbow Blvd # Ms 1060, Kansas City, KS 66160-8500 Ph: (913) 588-5276 |
News Archive
Almost half of pre-hurricane residents of New Orleans and one-fourth of those living in other affected areas had evidence of an anxiety or mood disorder five to seven months following Hurricane Katrina, according to a report in the December issue of Archives of General Psychiatry.
Lux Biosciences, Inc. today announced its submission of simultaneous regulatory filings to both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing approval for its investigational drug LUVENIQâ„¢ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.
Memories of events comprise many components-including sights, sounds, smells, and tastes. Somehow the many features of an episodic memory are woven together into a coherent whole, and researchers have had little understanding of how this binding takes place as the memories are processed by the brain's memory center, the hippocampus.
Consumer Watchdog called on the Obama Administration to adopt new regulations requiring broad financial disclosures by health insurance companies to help insulate Americans from double-digit rate increases. Insurers should provide details of shadowy multibillion-dollar transfers to out-of-state affiliates and parent companies when they are required to justify "unreasonable" rate increases under the health reform law, said the group.
› Verified 2 days ago